Review of new guidelines for prophylaxis and treatment of MRSA infections

British Journal of Hospital Medicine

Volumn 67, Issue 9, 2006, Pages 482-486

  French, Gary ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33749530238     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2006.67.9.22001     Document Type: Review

References (30)

1. Ayliffe GAJ, Buckles A, Casewell MW et al (1998) Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect 39: 253-90
2. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA (2002) Outcome and attributable mortality in critically ill patients with bacteraemia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 162: 2229-35
3. Brandt CM, Sistrunk WW, Duffy MC et al (1997) Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 24: 914-19
4. Brown DFJ, Edwards DI, Hawkey PM et al (2005) Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother 56: 1000-18
5. Cafferkey MT, Hone R, Coleman D et al (1985) Methicillin-resistant Staphylococcus aureus in Dublin. Lancet ii: 705-8
6. Gosgrove S, Sakoulas G, Peremcevitch EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteraemia: a meta-analysis. Clin Infect Dis 36: 53-9
7. Dacquet V (1996) Treatment of bone and joint infection with teicoplanin: a retrospective analysis of 50 cases. Int J Antimicrob Agents 7: 49-51
8. Elliott TSJ, Foweraker J, Gould FK, Perry JD, Sandoe JAT (2004) Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 54: 971-81
9. Eng RHK, Smith SM, Tillem M, Cherubin C (1998) Rifampicin resistance: development during the therapy of methicillin-resistant Staphylococcus aureus infection. Arch Intern Med 145: 146-8
10. Engemann JJ, Carmeli Y, Cosgrove S et al (2003) Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 36: 592-8
11. Garraud JJ, Regnier B, Lassoued K, Pangon B, Leport C (1985) Treatment of severe staphylococcal infections. Failure of rifampicin in combination therapy. Press Med 14: 1013-16
12. Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, Warren RE (2006) Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. J Antimicrob Chemother 57: 589-608
13. Glupczynski Y, Lagast H, Van der Auwera P et al (1986) Clinical evaluation of teicoplanin for therapy of severe infections caused by Gram-positive bacteria. Antimicrob Agents Chemother 29: 52-7
14. Gonzalez C, Rubio M, Romero-Vivas J, Gonzalez M, Picazo J (1999) Bacteremic pneumonia due to Staphylacoccus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 29: 1171-7
15. Cordts B, Firre E, Legrand J-C, Maertens J, Struelens M (2000) National guidelines for the judicious use of glycopeptides in Belgium. Clin Microbiol Infect 6: 585-92
16. Graninger W, Wenisch C, Wiesinger E, Menschik M, Karimi J, Presterl E (1995) Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis. Eur J Clin Microbiol Infect Dis 14: 643-7
17. Graziani AL, Lawson LA, Gibson GA, Steinberg MA, MacGregor RR (1988) Vancomycin concentrations in infected and non-infected human bone. Antimicrob Agents Chemother 32: 1320-2
18. Honeybourne D, Tobin C, Jevons G, Andrews J, Wise R (2003) Intrapulmonary penetration of linezolid. J Antimicrob Chemother 51: 1431-4
19. Jantausch BA, Deville JG, Adler S et al (2003) Linezolid for the treatment of children with bacteraemia or nosocomial pneumonia caused by resistant Gram-positive bacterial pathogens. Pediatr Infect Dis J 22: S164-S171
20. Kollef MH, Rello J, Cammarata SK, Croos-Dabrera RV, Wunderink RG (2004) Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of rwo double-blind studies comparing linezolid with vancomycin. Intensive Care Med 30: 388-94
21. Li Z, Wilke RJ, Pinto LA et al (2001) Comparison of length of hospital stay for patients with known or suspected merhicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: a randomized, multicenter trial. Pharmacotherapy 21: 263-74
22. Loeb M, Main C, Walker-Dilks C, Eady A (2003) Antimicrobial drugs for trearing methicillin-resistant Staphylococcus aureus colonization (Review). The Cochrane Database of Systematic Reviews 4: CD003340
23. Moise PA, Forrest A, Birmingham MC, Schentag JJ (2002) The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin. J Antimicrob Chemother 50: 1017-26
24. Moise PA, Schentag JJ (2000) Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections. Int J Antimicrob Agents 16(Suppl 1): S31-4
25. Nathwani D (2003) Impact of methicillin-resisrant Staphylococcus aureus infections on key health outcomes: does reducing the length of hospital stay matter? J Antimicrob Chemother 51(Suppl 2): 37-44
26. Shanson DC (1990) Clinical relevance of resistance to fusidic acid in Staphylococcus aureus. J Antimicrob Chemother 25(Suppl B): S15-21
27. Stevens DS, Herr D, Lampiris H, et al (2002) Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 34: 1481-90
28. Wilcox M, Nathwani D, Dryden M (2004) Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infection. J Antimicrob Chemother 53: 335-44
29. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH (2003) Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124: 1789-97
30. Youngman JR, Ridgway G, Haddad FS (2003) Antibiotic loaded cement in revision joint replacement. Hosp Med 64: 613-16